Series A

ENA Respiratory's INNA-051 nasal spray, a virus-agnostic shield, has begun Phase II trials, offering new hope for high-risk communities.

The acquisition integrates advanced clinical AI into EMRs, aiming to ease physician burnout and reshape Canada's competitive health tech market.

A historic wave of business acquisitions is set to reshape Canada's economy as owners retire, unlocking immense profits for savvy buyers.

With a $1.88M prize pool and 788 teams, WEEX's global AI hackathon is a high-stakes stress test for the next generation of automated finance.

GPU provider Hydaway Digital acquires AI detection startup RealityChek in a bid to fight deepfakes and gamify user growth for its compute platform.

In a stunning lean startup success, AI platform Kashie.AI, built for $300, is acquired by Launchpoint, signaling a major push into the music creator economy.

Nord Anglia Education empowers students to solve real-world problems, from building prosthetics to restoring coral reefs, through a unique metacognitive approach.

Scrum Alliance's new course helps agile teams move beyond activity tracking to prove their real business value with data-driven, outcome-focused metrics.

Resalis Therapeutics hires a key leader from a Novo Nordisk acquisition to steer its novel RNA therapy, which aims for fat loss without muscle waste.

A new global consortium aims to break the antibiotic R&D logjam, using open science and AI to combat the growing superbug crisis threatening millions.

India's 'Vaccine Capital' unveils a bold new policy at Davos, shifting from manufacturing to high-value innovation to join the world's top life sciences hubs.

LiveWorld unveils a new AI roadmap for pharma, promising a safer, human-guided approach to tackle compliance and build trust in a high-risk industry.

A new journal issue reveals how venture capital, advanced clinical insights, and patient-centered drug design are creating a new era in heart failure care.

An Israeli startup's laser-based processor is making waves in high-performance computing, offering a practical, room-temperature alternative to quantum.

As restaurants face a historic labor crisis, Aniai's automated Alpha Grill lands in U.S. kitchens, promising speed, consistency, and a new era of dining.

GSK's subsidiary Tesaro inks a deal worth up to $285M with Alteogen to create an under-the-skin version of its cancer drug Jemperli.

Deeplumen's new tool for Google's UCP signals a massive shift to 'agentic commerce,' where AIs shop for you. But are brands ready for this new world?

With its 'Infinite Ways to Earn' campaign, Mu Digital plans to tokenize Asia's vast credit market on the Monad blockchain, offering new, stable yields.

Following a spin-out and $5M financing, new explorer Blue Jay Gold aims to unlock value at its Steller Project and list on the TSX Venture Exchange.

Crosswalk Therapeutics secures a key grant to develop a therapy targeting the debilitating skeletal disease in Morquio A, a challenge current treatments can't solve.